Smart Diabetes Management Market – By Product Type , By Connectivity , By Application , By Patient Demographics , By End User , By Distribution Channel and By Geography - Opportunity Analysis & Industry Forecast, 2025-2031

Smart Diabetes Management Market Overview:

The Smart Diabetes Management Market size is estimated to reach $40.9 billion by 2031, growing at a CAGR of 18.4% during the forecast period 2025-2031. Smart Diabetes Management is driven by the rising prevalence of diabetes which creates an urgent need for effective management solutions. The demand for smart devices that offer real-time monitoring, personalized treatment plans and improved patient outcomes is growing as such innovations ensure better control and quality of life for individuals with diabetes. Artificial intelligence is transforming smart diabetes management by enabling predictive analytics, personalized recommendations and automated insulin delivery. AI-driven diabetes management apps such as those integrating with CGM and smart insulin pens offer users tailored suggestions for meal planning, medication adjustments and exercise routines. The shift toward personalized healthcare is reshaping smart diabetes management by emphasizing tailored treatment plans based on individual patient data. Smart diabetes devices, such as CGMs, smart insulin pumps and AI-powered mobile apps further enhance personalized treatment by offering real-time insights and adaptive recommendations. These factors positively influence the Smart Diabetes Management industry outlook during the forecast period.

Market Snapshot: 

Smart Diabetes Management Market - Report Coverage:

The “Smart Diabetes Management Market Report - Forecast (2025-2031)” by IndustryARC, covers an in-depth analysis of the following segments in the Smart Diabetes Management Market.

Key Takeaways:

North America Leads the Market

North America occupied the largest share in the market in 2024 driven by the region's high prevalence of diabetes and availability and adoption of smart medical devices. According to Diabetes Canada, every 3 minutes one person in Canada is diagnosed with diabetes. As such, there is a high demand for smart diabetes management solutions in the region. Additionally, regulatory approvals and insurance reimbursements in these countries accelerates the adoption of smart diabetes management. In October 2024, Insulcloud, a healthtech company revolutionizing diabetes management, announced its strategic expansion in the U.S. market after the Food and Drug Administration (FDA) clearance of its Insulclock CAP smart device, designed to monitor patient use of disposable insulin pens in real time and increase patient adherence to prescribed therapy.

Type 1 Diabetes is the Largest Segment

Type 1 diabetes is the largest segment in the smart diabetes management market due to the critical need for continuous glucose monitoring and insulin management. Type 1 diabetes patients cannot produce insulin, therefore constant monitoring and precise insulin administration is essential. Continuous glucose monitors (CGMs), insulin pumps and smart glucose meters have become indispensable for managing this condition effectively. In November 2024, Medtronic plc, a global leader in healthcare technology, announced FDA clearance for its new InPen app featuring missed meal dose detection. The growing availability of advanced digital solutions including closed-loop insulin delivery systems (also known as artificial pancreas systems), further enhances treatment outcomes for Type 1 diabetes patients. Additionally, government initiatives and insurance coverage boosts the adoption of smart diabetes management solutions. 

Smart Glucose Meters are the Largest Segment 

Smart glucose meters are the largest segment in the smart diabetes management market due to their widespread adoption and ease of use. These devices provide real-time blood glucose readings, allowing individuals to monitor their levels conveniently. Many smart glucose meters are integrated with mobile apps and cloud-based platforms, enabling seamless data tracking and sharing with healthcare providers. Their affordability compared to continuous glucose monitors (CGMs) further drives their dominance in the market. The growing diabetic population, particularly among elderly individuals and those managing Type 1 and Type 2 diabetes, further fuels demand. In May 2024, Smart Meter introduced a new version of the iGlucose, its patented cellular-connected glucose meter. The redesigned model, branded iGlucose Plus automatically transmits results to the patient’s provider using built-in cellular technology allowing real-time tracking of blood glucose levels from anywhere.

Continuous Glucose Monitoring (CGM) Drives the Market

Continuous glucose monitoring (CGM) is a key driver in the smart diabetes management market due to its ability to provide real-time, continuous tracking of blood glucose levels. Unlike traditional finger prick tests, CGM devices offer dynamic insights into glucose trends and enable proactive diabetes management. These devices help patients make informed lifestyle and medication decisions thereby also reducing the risk of complications such as hypoglycemia and hyperglycemia. According to Roche, diabetic people typically encounter an average of two hypoglycaemic episodes a week with 1-2 of these being severe enough to require medical intervention each year. As such, Roche’s new CGM solution is designed to alleviate diabetics and their caregivers concerns about nighttime hypoglycaemia and lower its risk. It aims to support informed therapy self-management decisions, enabling proactive intervention before glucose levels require immediate attention. Furthermore, advancements in CGM technology such as better sensor life, improved accuracy and integration with insulin pumps are further enhancing adoption. Additionally, CGM systems increasingly connect with smartphones and cloud-based platforms and allow seamless data sharing with healthcare providers.

For more details on this report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Smart Diabetes Management Market. The top 10 companies in this industry are listed below:

1. Medtronic plc
2. Eli Lilly and Company
3. Sanofi S.A.
4. F. Hoffmann-La Roche AG
5. Novo Nordisk A/S
6. Abbott Laboratories
7. Dexcom, Inc.
8. Ascensia Diabetes Care
9. Insulet Corporation
10. Glytec

Scope of the Report

For more Lifesciences and Healthcare Market reports, please click here